Clinical Trial Update: Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate NMS-03305293 in adults with relapsed ovarian cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• NMS-03305293

Snippet

Sponsor: Nerviano Medical Sciences | Conditions: Ovarian Cancer | Phase 1 | Status: RECRUITING